NM_001134363.3:c.1013T>C

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_001134363.3(RBM20):​c.1013T>C​(p.Met338Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000165 in 1,398,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M338R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

RBM20
NM_001134363.3 missense

Scores

4
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 1.62

Publications

1 publications found
Variant links:
Genes affected
RBM20 (HGNC:27424): (RNA binding motif protein 20) This gene encodes a protein that binds RNA and regulates splicing. Mutations in this gene have been associated with familial dilated cardiomyopathy. [provided by RefSeq, Apr 2014]
RBM20 Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • dilated cardiomyopathy 1DD
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.1529294).
BP6
Variant 10-110781622-T-C is Benign according to our data. Variant chr10-110781622-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 229181.
BS2
High AC in GnomAdExome4 at 23 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RBM20NM_001134363.3 linkc.1013T>C p.Met338Thr missense_variant Exon 2 of 14 ENST00000369519.4 NP_001127835.2 Q5T481
RBM20XM_017016103.3 linkc.848T>C p.Met283Thr missense_variant Exon 2 of 14 XP_016871592.1
RBM20XM_017016104.3 linkc.629T>C p.Met210Thr missense_variant Exon 2 of 14 XP_016871593.1
RBM20XM_047425116.1 linkc.629T>C p.Met210Thr missense_variant Exon 2 of 14 XP_047281072.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RBM20ENST00000369519.4 linkc.1013T>C p.Met338Thr missense_variant Exon 2 of 14 1 NM_001134363.3 ENSP00000358532.3 Q5T481
RBM20ENST00000718239.1 linkc.1013T>C p.Met338Thr missense_variant Exon 2 of 14 ENSP00000520684.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000129
AC:
2
AN:
155224
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000336
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000165
AC:
23
AN:
1398132
Hom.:
0
Cov.:
32
AF XY:
0.0000160
AC XY:
11
AN XY:
689342
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31542
American (AMR)
AF:
0.00
AC:
0
AN:
35660
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25138
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35712
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79218
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49258
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5694
European-Non Finnish (NFE)
AF:
0.0000195
AC:
21
AN:
1077968
Other (OTH)
AF:
0.0000345
AC:
2
AN:
57942
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary dilated cardiomyopathy Uncertain:1Benign:1
-
University of Washington Center for Mendelian Genomics, University of Washington
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

May 14, 2019
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Jun 22, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Met338Thr variant in RBM20 has not been previously reported in individuals with cardiomyopathy and was absent from large population studies. Computational prediction tools and conservation analysis suggest that the p.Met338Thr variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Met338Th r variant is uncertain. -

Cardiovascular phenotype Uncertain:1
Oct 02, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.M338T variant (also known as c.1013T>C), located in coding exon 2 of the RBM20 gene, results from a T to C substitution at nucleotide position 1013. The methionine at codon 338 is replaced by threonine, an amino acid with similar properties. This variant co-occurred with a TTN A-band truncating variant and variants in other cardiac-related genes in two affected individuals from a family with dilated cardiomyopathy (Cowan JR et al. Circ Genom Precis Med, 2018 Jul;11:e002038). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Dilated cardiomyopathy 1DD Benign:1
Apr 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.037
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
19
DANN
Uncertain
0.98
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.18
FATHMM_MKL
Uncertain
0.84
D
M_CAP
Benign
0.038
D
MetaRNN
Benign
0.15
T
MetaSVM
Benign
-0.69
T
PhyloP100
1.6
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-0.74
N
REVEL
Benign
0.24
Sift
Uncertain
0.0020
D
Sift4G
Benign
0.44
T
Vest4
0.30
MutPred
0.11
Gain of glycosylation at M338 (P = 9e-04);
MVP
0.36
ClinPred
0.19
T
GERP RS
4.6
gMVP
0.17
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs876657970; hg19: chr10-112541380; API